These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 18981304)

  • 1. Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding.
    Wang TY; Xiao L; Alexander KP; Rao SV; Kosiborod MN; Rumsfeld JS; Spertus JA; Peterson ED
    Circulation; 2008 Nov; 118(21):2139-45. PubMed ID: 18981304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study.
    Frilling B; Schiele R; Gitt AK; Zahn R; Schneider S; Glunz HG; Gieseler U; Jagodzinski E; Senges J;
    Am Heart J; 2004 Aug; 148(2):306-11. PubMed ID: 15309001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
    Aronow HD; Steinhubl SR; Brennan DM; Berger PB; Topol EJ;
    Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of early follow-up after acute myocardial infarction with higher rates of medication use.
    Daugherty SL; Ho PM; Spertus JA; Jones PG; Bach RG; Krumholz HM; Peterson ED; Rumsfeld JS; Masoudi FA
    Arch Intern Med; 2008 Mar; 168(5):485-91; discussion 492. PubMed ID: 18332293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events).
    Lim MJ; Eagle KA; Gore JM; Anderson FA; Dabbous OH; Mehta RH; Granger CB; Fox KA; Spencer FA; Goldberg RJ;
    Am J Cardiol; 2005 Oct; 96(7):917-21. PubMed ID: 16188516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of patients with acute myocardial infarction that may be discharged early: prospective evaluation with simple clinical and instrumental indicators].
    Murena E; Molero U; Moio N; Pisani A; Stingone MA; Guardascione A; Grassia V; Scilla C; Marino A; Sibilio G
    Ital Heart J Suppl; 2001 Jul; 2(7):775-82. PubMed ID: 11508296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
    Buresly K; Eisenberg MJ; Zhang X; Pilote L
    Arch Intern Med; 2005 Apr; 165(7):784-9. PubMed ID: 15824298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?
    Spencer FA; Moscucci M; Granger CB; Gore JM; Goldberg RJ; Steg PG; Goodman SG; Budaj A; FitzGerald G; Fox KA;
    Circulation; 2007 Dec; 116(24):2793-801. PubMed ID: 18025530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: results from the MITRA and MIR studies.
    Frilling B; Schiele R; Gitt AK; Zahn R; Schneider S; Glunz HG; Gieseler U; Baumgärtel B; Asbeck F; Senges J; ;
    Am Heart J; 2001 Feb; 141(2):200-5. PubMed ID: 11174332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of bleeding and compliance on prolonged dual antiplatelet therapy (aspirin + thienopyridine) following drug-eluting stent implantation.
    Latib A; Morici N; Cosgrave J; Airoldi F; Godino C; Brambilla N; Chieffo A; Bonizzoni E; Carlino M; Bedogni F; Montorfano M; Sangiorgi GM; Briguori C; Colombo A
    Am J Cardiol; 2008 Dec; 102(11):1477-81. PubMed ID: 19026299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of aspirin dosage to clinical outcomes after percutaneous coronary intervention: observations from the Ottawa Heart Institute PCI Registry.
    So D; Cook EF; Le May M; Glover C; Williams W; Ha A; Davies R; Froeschl M; Marquis JF; O'Brien E; Labinaz M
    J Invasive Cardiol; 2009 Mar; 21(3):121-7. PubMed ID: 19258643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
    Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
    Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?
    Nguyen MC; Lim YL; Walton A; Lefkovits J; Agnelli G; Goodman SG; Budaj A; Gulba DC; Allegrone J; Brieger D;
    Eur Heart J; 2007 Jul; 28(14):1717-22. PubMed ID: 17562671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding events with antithrombotic therapy in patients with unstable angina or non-ST-segment elevation myocardial infarction; insights from a large clinical practice registry (GRACE).
    Stiles MK; Dabbous OH; Fox KA;
    Heart Lung Circ; 2008 Feb; 17(1):5-8. PubMed ID: 17419100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of anticoagulant therapy with dual antiplatelet therapy on prognosis after treatment with drug-eluting coronary stents.
    Uchida Y; Mori F; Ogawa H; Takagi A; Hagiwara N
    J Cardiol; 2010 May; 55(3):362-9. PubMed ID: 20350510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38).
    Hochholzer W; Wiviott SD; Antman EM; Contant CF; Guo J; Giugliano RP; Dalby AJ; Montalescot G; Braunwald E
    Circulation; 2011 Jun; 123(23):2681-9. PubMed ID: 21606391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
    Toth PP
    Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
    Wang TH; Bhatt DL; Fox KA; Steinhubl SR; Brennan DM; Hacke W; Mak KH; Pearson TA; Boden WE; Steg PG; Flather MD; Montalescot G; Topol EJ;
    Eur Heart J; 2007 Sep; 28(18):2200-7. PubMed ID: 17673448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of female gender and transradial coronary stenting with maximal antiplatelet therapy on bleeding and ischemic outcomes.
    Tizón-Marcos H; Bertrand OF; Rodés-Cabau J; Larose E; Gaudreault V; Bagur R; Gleeton O; Courtis J; Roy L; Poirier P; Costerousse O; De Larochellière R
    Am Heart J; 2009 Apr; 157(4):740-5. PubMed ID: 19332204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.